Watanabe Masayuki | Researcher Information

2022 - 2025 胃切除後の血糖変動を考慮した個別化栄養介入によるダンピング症候群の克服
2022 - 2025 食道癌手術後の呼吸器合併症減少を目指した革新的リスク評価法の確立
2019 - 2022 Molecular mechanism and novel target of diffuse histological type of non-EBV/non-MSI-H esophagogastric junction adenocarcinoma
2019 - 2022 Comprehensive analyses of the importance of mean corpuscular volume to estimate short-term and long-term outcomes in patients with esophageal squamous cell carcinoma who undergo esophagectomy
2017 - 2019 Epigenetic analysis for a novel therapeutic target in esophagogastric junction adenocarcinoma

2015 - 2018 Global genomic analysis of the stromal compartments of the esophagus toward the establishment of novel treatment for esophageal cancer.

2014 - 2017 Comprehensive analysis of mutation in PI3K/AKT pathway genes in esophageal cancer.

2014 - 2017 TET family proteins and 5-hydroxymethylcytosine in gastrointestinal carcinoma.

2014 - 2017 The identification of novel microRNAs regulating cancer stem cell properties and the clinical application to therapeutic strategy in gastrointestinal cancer

2015 - 2016 消化管癌の新規バイオマーカー開発をめざしたDNA脱メチル化関連酵素の網羅的解析

2013 - 2016 Clarification of the lipid metabolism concerning progression of gastrointestinal cancer, followed by developing new therapy.

2013 - 2016 Function analysis of SPINK1 in normal gastric mucosa epithelium and gastric cancer

2013 - 2016 Tumor-suppressive effects and mechanism of a novel PPAR gamma agonist in esophageal caner

2013 - 2016 The Molecular mechanism of trastuzumab for gastric cancer via microRNA –gene pathway

2013 - 2016 Comprehensive analysis of expression and function of lincRNA in gastroenterological cancer

2012 - 2015 Development of new epigenetic therapy for colon cancer

2012 - 2015 Comprehensive analysis of LINE-1 methylation level in gastric cancer.

2011 - 2013 The significance of transcription-reverse transcription concerted reaction method for detecting circulating tumor cells in patients with colorectal cancer and for anticancer drug sensitivity marker.

2011 - 2013 Pseudogene affected gene expression via regulating microRNA in esopheal squamous cancer

2011 - 2012 The identification of miR-gene pathway regulating the sensitivity of platinum agentsfor gastric cancer and its clinical applicatio

2011 - 2012 The elucidation of the novel microRNA-gene pathway regulating the peritoneal dissemination in gastric cancer

2011 - 2012 Can mTOR become target of the molecular target therapy in esophagus squamous cell carcinoma?

2010 - 2012 Clinical significance of serum exosomal micro RNA in human esophageal squamous cellcarcinoma

1999 - 2000 食道癌発生における遺伝子異常およびシグナル伝達機構解析の意義に関する研究

1998 - 1999 中国食道癌多発地域および本邦における食道癌化機構の比較検討-マイクロサテライト不安定性解析による検討-

Show all

Keisuke Kosumi, Yoshifumi Baba, Kensuke Yamamura, Daichi Nomoto, Kazuo Okadome, Taisuke Yagi, Tasuku Toihata, Yuki Kiyozumi, Kazuto Harada, Kojiro Eto, et al. Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer. British journal of cancer. 2023. 128. 6. 1155-1165
Akihiko Okamura, Masayuki Watanabe, Jun Okui, Satoru Matsuda, Ryo Takemura, Hirofumi Kawakubo, Hiroya Takeuchi, Manabu Muto, Yoshihiro Kakeji, Yuko Kitagawa, et al. ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma. Annals of surgical oncology. 2022. 30. 4. 2186-2187
Akihiko Okamura, Masayuki Watanabe, Jun Okui, Satoru Matsuda, Ryo Takemura, Hirofumi Kawakubo, Hiroya Takeuchi, Manabu Muto, Yoshihiro Kakeji, Yuko Kitagawa, et al. Development and Validation of a Predictive Model of Therapeutic Effect in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment: A Nationwide Retrospective Study in Japan. Annals of surgical oncology. 2022. 30. 4. 2176-2185
Satoru Matsuda, Yuko Kitagawa, Hirofumi Kawakubo, Jun Okui, Akihiko Okamura, Ryo Takemura, Manabu Muto, Yoshihiro Kakeji, Hiroya Takeuchi, Masayuki Watanabe, et al. A nationwide validation of the prognostic impact of pathological response and the distribution of recurrence patterns in responders after neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Esophagus : official journal of the Japan Esophageal Society. 2022. 20. 2. 205-214
Satoru Matsuda, Yuko Kitagawa, Jun Okui, Akihiko Okamura, Hirofumi Kawakubo, Ryo Takemura, Manabu Muto, Yoshihiro Kakeji, Hiroya Takeuchi, Masayuki Watanabe, et al. Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Annals of surgery. 2022. 278. 2. e234-e239

ｍore...

Hideyuki Shimizu, Morihito Okada, Akira Tangoku, Yuichiro Doki, Shunsuke Endo, Hirotsugu Fukuda, Yasutaka Hirata, Hisashi Iwata, Junjiro Kobayashi, Hiraku Kumamaru, et al. Thoracic and cardiovascular surgeries in Japan during 2017: Annual report by the Japanese Association for Thoracic Surgery. General Thoracic and Cardiovascular Surgery. 2020. 68. 4. 414-449
Yu Imamura, Tasuku Toihata, Manabu Takamatsu, Norio Tanaka, Shinji Mine, Seiichi Mori, Eiji Oki, Masaru Morita, Hideo Baba, Takeshi Sano, et al. MSI-low is an intermediate type between MSI-high and MSS in esophagogastric junction adenocarcinoma. JOURNAL OF CLINICAL ONCOLOGY. 2019. 37. 4
Yu Imamura, Shinji Mine, Naoki Hiki, Eiji Oki, Manabu Yamamoto, Masaru Morita, Yoshihiko Maehara, Hideo Baba, Takeshi Sano, Masayuki Watanabe. Molecular Status Changes According to Tumor Location in EGJ Adenocarcinoma Abstracts. DIGESTION. 2019. 99. 1. 100-101
石本崇胤, 三宅慧輔, 八代正和, 内原智幸, 有馬浩太, 泉大輔, 岩槻政晃, 馬場祥史, 渡邊雅之, TAN Patrick, et al. 腫瘍炎症環境において間質に依存する胃癌進展の分子メカニズム. 日本外科学会定期学術集会(Web). 2018. 118th. ROMBUNNO.SF-009-7 (WEB ONLY)
吉田直矢, 馬場祥史, 黒田大介, 宮本裕士, 岩槻政晃, 石本崇胤, 日吉幸晴, 辛島龍一, 澤山浩, 渡邊雅之, et al. 食道癌術前の低栄養と術後重症合併症は独立した予後不良因子である. 日本外科学会定期学術集会(Web). 2018. 118th. ROMBUNNO.WS-7-11 (WEB ONLY)

ｍore...